HistologiX is thrilled to announce that they’ve recently added Visiopharm to their Digital Pathology service, alongside the gold standard image analysis platform, HALO™ from Indica Labs.
HistologiX are world experts in cellular and digital pathology, based at BioCity Nottingham, a Pioneer Group location.
With Visiopharm’s advanced AI technology and flexible workflows, they can work more efficiently and with higher throughput, delivering faster and results of higher quality to their clients. This allows your team to make critical decisions with confidence and without delay, while their advanced analytics capabilities provide new insights and enable them to extract more value from your data. By doing so, they can offer you better decision-making tools and more actionable recommendations.
Visiopharm’s flexibility and AI technology also allow them to create bespoke and personalised workflows that meet your project’s particular needs. Whether they’re working with unique tissues or biomarkers, or tailoring the workflow to specific requirements, they can provide you with more accurate and relevant results.
This means they can offer a truly personalised service that sets us apart from other CROs, providing you with a unique and valuable service meeting your exact needs.
